This topic contains a solution. Click here to go to the answer

Author Question: The above figure shows the isoquants for producing steel. Decreasing returns to scale are A) ... (Read 69 times)

xroflmao

  • Hero Member
  • *****
  • Posts: 515
The above figure shows the isoquants for producing steel. Decreasing returns to scale are
 
  A) present when producing more than 10,000 tons.
  B) present when producing more than 20,000 tons.
  C) present when producing more than 30,000 tons.
  D) never present.

Question 2

Describe the characteristics of an efficient contract between a principal and an agent.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

karlss

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

B

Answer to Question 2

An efficient contract is efficient in production. The principal's and agent's combined value of the contract is maximized. An efficient contract is also efficient in risk bearing. The risk sharing is optimal so that a relatively less risk-averse person bears more of the risk.




xroflmao

  • Member
  • Posts: 515
Reply 2 on: Jul 1, 2018
YES! Correct, THANKS for helping me on my review


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library